tert-Butyl 4-(5-(hydroxymethyl)pyridin-2-yl)piperazine-1-carboxylate

Catalog No.: 
ACJKYF378
CAS No.: 
857284-20-9
Molecular Formula: 
C15H23N3O3
Molecular Weight: 
293.37
tert-Butyl 4-(5-(hydroxymethyl)pyridin-2-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$338.00InquiryInquiry
1g95%$637.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(5-(hydroxymethyl)pyridin-2-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(5-(hydroxymethyl)pyridin-2-yl)piperazine-1-carboxylate
Molecular FormulaC15H23N3O3
Molecular Weight293.37
SMILESO=C(N1CCN(C2=NC=C(CO)C=C2)CC1)OC(C)(C)C
InChI KeyQKCHWJYIPFBVRD-UHFFFAOYSA-N
SynonymN4-[5-(HYDROXYMETHYL)PYRID-2-YL]PIPERAZINE, N1-BOC PROTECTED;TERT-BUTYL 4-[5-(HYDROXYMETHYL)PYRID-2-YL]PIPERAZINE-1-CARBOXYLATE;N4-[5-(Hydroxymethyl)pyrid-2-yl]piperazine, N1-BOC protected 97%;N1-BOC-N4-[5-(HYDROXYMETHYL)PYRID-2-YL]PIPERAZINE;tert-butyl 4-(5-(hydroxymethyl)pyridin-2-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[5-(hydroxymethyl)-2-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.857284-20-9

Synthetic Route by SureRoute

1. ACJKYF378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUZDB873 route compound structure diagram
    ACUZDB873479226-10-3In Stock
  2. Then
  3. ACJKYF378 route product structure diagram
    ACJKYF378857284-20-9
Inquiry

2. ACJKYF378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJKYF378 route product structure diagram
    ACJKYF378857284-20-9
Inquiry

3. ACJKYF378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJKYF378 route product structure diagram
    ACJKYF378857284-20-9
Inquiry

Comments (0)